Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT was superior to multiparametric MRI for primary locoregional staging of prostate cancer, according to results from a phase II ...

A deep learning model was as effective as radiologists in detecting clinically significant prostate cancer on multiparametric MRI, a retrospective study suggested. In an internal test set of 400 ...

Enhancing PSA-based screening with multiparametric magnetic resonance imaging (MRI) improves detection of prostate cancer among men with germline mutations while reducing unnecessary biopsies. For men ...

About The Study: In men with suspected prostate cancer, provided image quality is adequate, an abbreviated biparametric magnetic resonance imaging (MRI) scan, with or without targeted biopsy, could ...

Multiparametic MRI findings added to conventional clinical predictors decreases the number of false-positive biopsy results without increasing the number of clinically significant tumors left ...

Multiparametric MRI is the standard for detecting the presence of clinically significant prostate cancer. Accurate PI-RADS classification guides whether a patient should receive a biopsy.

Sequential flotufolastat-F18 PSMA-PET scans to enhance detection of prostate cancer in patients with early PSA recurrence following radical prostatectomy. Prevalence of treatment-acquired homozygous ...

A new international study from UCL and UCLH that aims to improve the quality of MRI scans for prostate cancer screening has identified simple ways to treble the number of scans that are of optimal ...

Please provide your email address to receive an email when new articles are posted on . First-line biparametric MRI testing increased the number of biopsies and overdiagnoses vs. first-line PSA ...

A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score identifies clinically significant disease, according to a study published in ...